An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD
This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Suzanne "Sue" Sisley MD
- Start date
- 2026-02-09
- End date
- 2026-03-01
- Registry ID
- NCT07275970
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.